+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dental Bone Graft Substitutes Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • PDF Icon


  • 115 Pages
  • August 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 5394087
The dental bone graft substitutes market is expected to witness a CAGR of 6.8% over the forecast period, 2022-2027.

The COVID-19 pandemic is an unprecedented health concern and has impacted industries worldwide. As all healthcare providers were engaged with COVID-19, access was restricted to essential care only, and the temporary closure of dental clinics drastically reduced dental surgeries. For instance, the American Dental Association (ADA) recommended that elective dental procedures be postponed until April 6, 2020, and dental practices should provide emergency-only dental services. Additionally, as per April 1, 2020, update, the ADA advised offices to remain closed to all but urgent and emergency procedures until April 30, at the earliest, owing to increasing COVID-19 cases. As a result, access to dental care has substantially decreased. Moreover, in March 2020, and ADA health policy institute survey indicated that 76% of dental offices surveyed were closed but seeing emergency patients only, 19% were completely closed, and 5% were open but seeing a lower volume of patients. These factors severely impacted dental bone graft substitute manufacturers and their supply chains. Thus, these statistics indicate that the demand for dental bone graft substitutes was reduced during the COVID-19 pandemic.

Furthermore, the significant factors responsible for the market's growth include the rising demand for medical and dental tourism, the increasing burden of dental diseases, and technological advancements in dentistry. The rising burden of dental diseases is driving the market's growth. For instance, according to the World Health Organization (2020), oral diseases affect nearly 3.5 billion people, and over 530 million children suffer from caries of their primary teeth.

To maintain the existing jaw, bone grafting is done before implant placement, which helps with successful implant surgery. Thus, increasing the use of such synthetic and biocompatible grafts in dental procedures ultimately triggers the market's growth. As per a May 2020 published study titled "Global Prevalence of Periodontal Disease and Lack of Its Surveillance," periodontitis was most common in older people and populations from high-income countries. The distribution differed significantly in low (28.7%), lower-middle (10%), upper-middle (42.5%), and high-income countries (43.7%). Additionally, according to the International Dental Journal’s article titled, "Risk Indicators of Tooth Loss among the Mexican Adult Population: A Cross-Sectional Study," published in February 2021, tooth loss was 57.2% due to tooth decay in Mexico. Hence, owing to the aforementioned factors, the market is expected to witness significant growth in the future.

However, expensive dental procedures and reimbursement issues hinder the market's growth.

Key Market Trends

The Xenogaft Segment is Expected to Grow Over the Forecast Period

The xenograft segment is expected to hold a significant market share by type. A xenograft is an organ transplant or a tissue graft to an individual of another species. Xenografts are obtained from pigs (porcine) or cows (bovine) and are prepared for implantation into the human body once thoroughly cleaned and sterilized. Deproteinized bovine bone is the most common source of xenograft materials in dentistry. A few commercially available xenografts are Bio-Oss, Bio-Oss Collagen, Pepgen-P15, etc. As xenograft is the most affordable, the key players in the market are taking initiatives to launch new products.

For instance, in March 2022, Fredun Pharmaceuticals Limited received approval to manufacture Xenografts for various dental and orthopedic surgical appliances from the Central Drugs Standard Control Organisation (COSCO), India. With this, the company aims to penetrate the dental fraternity across India. Such developments are expected to fuel the development of dental bone graft substitutes for xenografts, thereby boosting the segment's growth.

Thus, the segment is expected to witness significant growth over the forecast period due to the abovementioned factors.

North America Dominates the Market and Expected to do Same in the Forecast Period

The United States has held a significant market share in the dental bone graft substitute market. The major factors contributing to the market's growth are strategic initiatives undertaken by the market players and the growing number of dental visits.

For instance, according to the Centers for Disease Control and Prevention (CDC) data updated in January 2021, 1 in 4 adults between 20-64 years of age suffer from at least one cavity, and almost 57% of adolescents aged 12-19 have had a hole in their permanent teeth. Also, as per December 2020 statistics by the Centers for Disease Control and Prevention (CDC), more than 1 in 4 (26%) adults have untreated tooth decay, and nearly half (46%) of all adults aged 30 years or older show signs of gum disease; and severe gum disease affects about 9% of adults in the United States. Moreover, the increasing number of dental visits contributes to the market's growth. For instance, as per an August 2021 update by the Centers for Disease Control and Prevention (CDC), in 2019, 64.9% of adults aged 18 and above had dental visits in the United States. These statistics indicate that the percentage of the population visiting dental clinics for examinations contributes to the market growth.

Furthermore, Dentsply Sirona acquired Datum Dental Ltd., known for innovative dental regeneration products, in January 2021. With this acquisition, Dentsply Sirona promotes the complete OSSIX portfolio, including OSSIX Plus, OSSIX Volumax, and OSSIX Bone, in the United States, Canada, and several other countries.

Thus, the market is expected to witness significant growth over the forecast period due to the abovementioned factors.

Competitive Landscape

The dental bone graft substitutes market is highly competitive, with several players worldwide. In terms of market share, few significant players currently dominate the market. With the rising patient awareness levels and high prevalence of dental disorders, many regional players are expected to be part of the dental bone graft substitute market over the forecast period. Some of the market's major players are Dentsply Sirona, Johnson & Johnson, Institut Straumann AG, Medtronic PLC, ZIMMER BIOMET, etc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand of Medical and Dental Tourism
4.2.2 Rising Burden of Dental Diseases
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 Expensive Dental Procedures
4.3.2 Reimbursement Issues
4.4 Industry Attractiveness - Porter's Five Forces Analysis
4.4.1 Bargaining Power of Buyers/Consumers
4.4.2 Bargaining Power of Suppliers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Type
5.1.1 Xenograft
5.1.2 Allograft
5.1.3 Autograft
5.1.4 Other Types
5.2 By Mechanism
5.2.1 Osteoconduction
5.2.2 Osteoinduction
5.2.3 Osteogenesis
5.2.4 Osteopromotion
5.3 By End Users
5.3.1 Hospitals
5.3.2 Dental Clinics
5.3.3 Other End Users
5.4 By Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Dentsply Sirona
6.1.2 Johnson & Johnson
6.1.3 Institut Straumann AG
6.1.4 Medtronic PLC
6.1.6 Geistlich Pharm
6.1.7 Dentium
6.1.8 LifeNet Health
6.1.9 Collagen Matrix Inc.
6.1.10 Halma plc (Novabone LLC)
6.1.11 Botiss biomaterials GmbH
6.1.12 Wright Medical Group NV

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Dentsply Sirona
  • Johnson & Johnson
  • Institut Straumann AG
  • Medtronic PLC
  • Geistlich Pharm
  • Dentium
  • LifeNet Health
  • Collagen Matrix Inc.
  • Halma plc (Novabone LLC)
  • Botiss biomaterials GmbH
  • Wright Medical Group NV